chr2-202532735-A-T
Variant summary
Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PM1_StrongPP3PS1_SupportingPM2_Supporting
This summary comes from the ClinGen Evidence Repository: The BMPR2 c.1276+3A>T variant is a non-canonical splice site (+3) variant located in intron 9. The variant is absent from gnomAD v.2.1.1 and v4.1.0 (PM2_supporting) and was reported in a single proband with heritable PAH (PMID:20534176). In silico prediction (SpliceAI = 0.97) indicates the variant will probably impact splicing with loss of the canonical donor site in intron 9 (PP3). This predicted splicing event matches a known likely pathogenic variant (c.1276+4A>G) within the same donor site (PS1_supporting) (PMID:37352859). Exon skipping or use of a cryptic splice site would disrupt the region encoding the conserved intracellular kinase domain (PM1_strong). No familial segregation data were available, and no functional analysis has been reported for this variant. In summary, the variant meets the criteria to be classified as likely pathogenic for pulmonary arterial hypertension based on the ACMG/AMP criteria applied, as specified by the ClinGen Pulmonary Hypertension VCEP: PM1_strong, PS1_supporting, PM2_supporting, PP3 (VCEP specification version v1.1, 1/18/2024). LINK:https://erepo.genome.network/evrepo/ui/classification/CA645293834/MONDO:0015924/125
Frequency
Consequence
NM_001204.7 splice_region, intron
Scores
Clinical Significance
Conservation
Publications
- pulmonary arterial hypertensionInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- pulmonary hypertension, primary, 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
- heritable pulmonary arterial hypertensionInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- congenital heart diseaseInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 7 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| BMPR2 | ENST00000374580.10 | c.1276+3A>T | splice_region_variant, intron_variant | Intron 9 of 12 | 1 | NM_001204.7 | ENSP00000363708.4 | |||
| BMPR2 | ENST00000374574.2 | c.1276+3A>T | splice_region_variant, intron_variant | Intron 9 of 11 | 2 | ENSP00000363702.2 | 
Frequencies
GnomAD3 genomes  
GnomAD4 exome Cov.: 31 
GnomAD4 genome  
ClinVar
Submissions by phenotype
Pulmonary arterial hypertension    Pathogenic:1 
The BMPR2 c.1276+3A>T variant is a non-canonical splice site (+3) variant located in intron 9. The variant is absent from gnomAD v.2.1.1 and v4.1.0 (PM2_supporting) and was reported in a single proband with heritable PAH (PMID: 20534176). In silico prediction (SpliceAI = 0.97) indicates the variant will probably impact splicing with loss of the canonical donor site in intron 9 (PP3). This predicted splicing event matches a known likely pathogenic variant (c.1276+4A>G) within the same donor site (PS1_supporting) (PMID: 37352859). Exon skipping or use of a cryptic splice site would disrupt the region encoding the conserved intracellular kinase domain (PM1_strong). No familial segregation data were available, and no functional analysis has been reported for this variant. In summary, the variant meets the criteria to be classified as likely pathogenic for pulmonary arterial hypertension based on the ACMG/AMP criteria applied, as specified by the ClinGen Pulmonary Hypertension VCEP: PM1_strong, PS1_supporting, PM2_supporting, PP3 (VCEP specification version v1.1, 1/18/2024). -
Pulmonary hypertension, primary, 1    Pathogenic:1 
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at